FDA inspection
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.: FDA inspection ending Sep 5, 2025
FDA inspection 1286526 · No Action Indicated (NAI) · Shizuishan
Key facts
| Inspection ID | 1286526 |
|---|---|
| Firm | Livzon Group (Ningxia) Pharmaceutical Co., Ltd. |
| FEI number | 3012375554 |
| Address | Pingluo Industrial Park, Toushi Road West,301 Provincial Highway South |
| City | Shizuishan |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Sep 5, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data